Biomarkers tagged posts

Research findings focus on people with a sleep disorder, but could have broader implications. For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before symptoms appear, a new study indicates.

Idiopathic REM sleep behaviour disorder (iRBD) causes people to physically act out their dreams while sleeping.

The disorder is also associated with a very high risk of Parkinson’s disease and a related condition called Dementia with Lewy Bodies.

This is a form of dementia that often causes memory and cognitive loss, as well as vivid visual hallucinations and movement difficulties similar to Parkinson’s.

McGill University researchers have discovered that a blood test, originally developed to detect Alzheimer’s disease, co...

Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain. The analysis, led by researchers at Imperial College London and the UK Dementia Research Institute, found that people who had previously had COVID-19 were more likely to have increased levels of biomarkers linked to faulty amyloid proteins—a known hallmark for Alzheimer’s disease.

On average, the effects were comparable to four years of aging with the greatest effects seen in those hospitalized with severe COVID-19 or with underlying risk factors for dementia such as smoking or high blood pressure.

According to the researchers, the findings suggest that mild or moderate COVID-19 may acceler...

Heart failure is a leading cause of death worldwide and is especially deadly for people who don’t have access to medical facilities. A team of researchers aims to bring heart failure screening from the lab to the home with a point-of-care electrochemical biosensor prototype that measures levels of two biomarkers for heart failure in as little as 15 minutes from just a drop of saliva.

Trey Pittman, a graduate student at Colorado State University, will present his team’s research at the fall meeting of the American Chemical Society (ACS).

“Our device would be ideal for people who are at high risk for heart failure but have limited access to a ...

Dementia, which includes Alzheimer’...